Glanzmann Thrombasthenia Therapeutic Drug Market
This report contains market size and forecasts of Glanzmann Thrombasthenia Therapeutic Drug in Gl ... Read More
This report contains market size and forecasts of ICU-acquired Acute Kidney Treatment in Global, including the following market information:
Global ICU-acquired Acute Kidney Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global ICU-acquired Acute Kidney Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pre-renal Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of ICU-acquired Acute Kidney Treatment include Quark Pharmaceuticals, Fresenius Medical Care, B. Braun, Baxter international, Angion Biomedica Corp and Asahi Kasei Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ICU-acquired Acute Kidney Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ICU-acquired Acute Kidney Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global ICU-acquired Acute Kidney Treatment Market Segment Percentages, by Type, 2021 (%)
Pre-renal
Intrinsic-renal
Post-renal
Global ICU-acquired Acute Kidney Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global ICU-acquired Acute Kidney Treatment Market Segment Percentages, by Application, 2021 (%)
Public Hospital
Private Hospital
Global ICU-acquired Acute Kidney Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global ICU-acquired Acute Kidney Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies ICU-acquired Acute Kidney Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies ICU-acquired Acute Kidney Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Quark Pharmaceuticals
Fresenius Medical Care
B. Braun
Baxter international
Angion Biomedica Corp
Asahi Kasei Medical
This report contains market size and forecasts of Glanzmann Thrombasthenia Therapeutic Drug in Gl ... Read More
This report contains market size and forecasts of EtCO2 Masks in global, including the following ... Read More
This report contains market size and forecasts of OX40 Receptor Agonist in global, including the ... Read More
This report contains market size and forecasts of Laboratory Infrastructure in global, including ... Read More